A 72-year-old woman with chronic kidney disease (baseline creatinine 2.8 mg/dL) and indwelling urinary catheter is admitted with a 3-day history of fever (38.8°C), confusion, and hypotension (BP 82/48 mmHg). She is tachycardic (HR 125/min) and tachypneic (RR 32/min). Laboratory findings: WBC 22,000/μL, lactate 5.8 mmol/L, creatinine 3.9 mg/dL, platelets 85,000/μL. Urine is turbid and foul-smelling. Blood cultures are drawn. After receiving 2 L of normal saline over 1 hour, her BP remains 85/50 mmHg and lactate is still 5.6 mmol/L. What is the next most appropriate step?

Explanation

## Septic Shock: Vasopressor Escalation and Refractory Hypotension ### Clinical Context: Fluid-Refractory Shock This patient has received adequate initial fluid resuscitation (30 mL/kg crystalloid) yet remains hypotensive with persistent elevated lactate. This defines **fluid-refractory septic shock** — the point at which vasopressors become mandatory. ### Vasopressor Selection and Targets **Key Point:** Norepinephrine is the first-line vasopressor in septic shock (SSC 2021). | Vasopressor | Mechanism | Dosing | When to Use | |---|---|---|---| | **Norepinephrine** | α1 + β1 (dose-dependent) | 0.01–3 μg/kg/min IV | First-line; maintains MAP and renal perfusion | | Dopamine | Dose-dependent (low: renal; high: α) | 5–20 μg/kg/min | Second-line if NE unavailable | | Epinephrine | α + β (high dose) | 0.05–2 μg/kg/min | Refractory shock or low HR | | Vasopressin | V1 receptor agonist | 0.03–0.04 U/min fixed | Adjunct to NE in refractory shock | | Phenylephrine | Pure α1 | 0.5–1.4 μg/kg/min | Avoid monotherapy; risk of reflex bradycardia | **High-Yield:** Target MAP ≥65 mmHg. Do NOT target higher MAP in sepsis (increases mortality and MI risk). ### Why This Patient Needs Vasopressors Now - **Persistent hypotension** (82→85 mmHg) despite 2 L crystalloid - **Persistent elevated lactate** (5.8→5.6 mmol/L) = ongoing tissue hypoperfusion - **Multi-organ dysfunction:** AKI (Cr 3.9), thrombocytopenia (85k), confusion (encephalopathy) - **Source:** Catheter-associated UTI/urosepsis with likely Gram-negative organism **Clinical Pearl:** Lactate clearance is a key marker of resuscitation adequacy. Failure to clear lactate by ≥10% in 6 hours predicts ICU admission and mortality. This patient's lactate has not improved — vasopressor support is needed. ### SSC Algorithm for Septic Shock ```mermaid flowchart TD A["Sepsis suspected"]:::outcome --> B["Blood cultures + broad-spectrum antibiotics"]:::action B --> C["Fluid bolus: 30 mL/kg crystalloid"]:::action C --> D{"BP improved & Lactate cleared?"}:::decision D -->|Yes| E["Continue antibiotics + source control"]:::action D -->|No| F["Reassess volume status"]:::decision F -->|Euvolemic| G["Start norepinephrine (target MAP ≥65)"]:::action F -->|Hypovolemic| H["Give additional fluid bolus"]:::action G --> I["ICU admission + invasive monitoring"]:::action H --> D I --> J["Reassess lactate at 6 hours"]:::decision J -->|Cleared| K["Continue current regimen"]:::action J -->|Persistent| L["Consider hydrocortisone + vasopressin"]:::action ``` ### Adjunctive Therapies (Not First-Line) - **Hydrocortisone:** Reserved for refractory shock (after NE + fluids fail); SSC recommends against routine use - **Blood transfusion:** Only if Hb <7 g/dL (this patient is not yet there); transfusion in sepsis increases mortality - **Activated protein C:** No longer recommended (PROWESS-SHOCK trial negative) **Mnemonic: MAP ≥65, NE first, ICU now — the "3-65 rule" for septic shock** [cite:Surviving Sepsis Campaign 2021 Guidelines; Harrison 21e Ch 297]